0001894562-24-000040.txt : 20240614
0001894562-24-000040.hdr.sgml : 20240614
20240614165916
ACCESSION NUMBER: 0001894562-24-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240612
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schenkein David P
CENTRAL INDEX KEY: 0001578200
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41536
FILM NUMBER: 241045711
MAIL ADDRESS:
STREET 1: C/O BLUEBIRD BIO, INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prime Medicine, Inc.
CENTRAL INDEX KEY: 0001894562
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 FIRST ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-465-0013
MAIL ADDRESS:
STREET 1: 60 FIRST ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
wk-form4_1718398747.xml
FORM 4
X0508
4
2024-06-12
0
0001894562
Prime Medicine, Inc.
PRME
0001578200
Schenkein David P
C/O PRIME MEDICINE, INC.
60 FIRST STREET
CAMBRIDGE
MA
02141
1
0
0
0
0
Stock Option (right to buy)
7.68
2024-06-12
4
A
0
45000
0
A
2034-06-12
Common Stock
45000
45000
D
The shares subject to this option shall vest in full upon the earlier of (i) June 12, 2025 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date
/s/ Karen Brown, attorney-in-fact
2024-06-12